Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
65.9M
-
Shares change
-
+1.43M
-
Total reported value, excl. options
-
$227M
-
Value change
-
+$4.75M
-
Number of buys
-
46
-
Number of sells
-
-22
-
Price
-
$3.45
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q4 2019
87 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q4 2019.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.9M shares
of 170M outstanding shares and own 38.69% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (21.6M shares), Sumitomo Mitsui Trust Holdings, Inc. (8.27M shares), Nikko Asset Management Americas, Inc. (8.27M shares), ARK Investment Management LLC (7.27M shares), FMR LLC (6.5M shares), BlackRock Inc. (4M shares), VANGUARD GROUP INC (2.14M shares), RENAISSANCE TECHNOLOGIES LLC (1.12M shares), STATE STREET CORP (703K shares), and GEODE CAPITAL MANAGEMENT, LLC (621K shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.